Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Ref Type | |||||||||||||
PMID | |||||||||||||
Authors | Peggy A Thompson, Nathan P Young, Craig R Stumpf, Boreth Eam, Vikas K Goel, Joan Chen, Sarah Fish, Gregory S Parker, Adina Gerson-Gurwitz, Maria Barrera, Eric Sung, Jocelyn Staunton, Gary G Chiang, Christopher J Wegerski, Samuel Sperry, Kevin R Webster and Siegfried H Reich | ||||||||||||
Title | eFT226, a first in class inhibitor of eIF4A1, targets FGFR1/2 and HER2 driven cancers | ||||||||||||
|
|||||||||||||
URL | https://mct.aacrjournals.org/content/18/12_Supplement/B133 | ||||||||||||
Abstract Text | Mol Cancer Ther 2019;18(12 Suppl):Abstract nr B133 |